< -5%

-5% to -3%

Arunjyoti Bio

Kohinoor Foods

Himalaya Food 

Saptarishi Agro

KLRF

GRM Overseas

-3% to 0%

Regaal Resource

KRBL

Pajson Agro Ind

Sayaji Industri

Chaman Lal Seti

NHC Foods

Mishtann Foods

Guj Amb Exports

Narmada Agrobas

SKM Egg Product

0% to 3%

Neopolitan Pizz

Tarai Foods

3% to 5%

SBI's market cap surpasses Rs10 lakh crore, now India's 6th most valuable firm., SBI overtakes ICICI Bank as second-most valuable bank after strong Q3 earnings, SBI shares hit record high, driven by robust profit and improved asset quality

* SBI's market cap surpasses Rs10 lakh crore, now India's 6th most valuable firm.
* SBI overtakes ICICI Bank as second-most valuable bank after strong Q3 earnings
* SBI shares hit record high, driven by robust profit and improved asset quality

State Bank of India’s market cap crossed Rs10 lakh crore, making it India’s sixth most valuable listed firm. SBI overtook ICICI Bank as the second-most valuable bank, driven by strong earnings, improved asset quality, and robust credit growth.

shorts/business/sbi-becomes-sixth-indian-firm-to-cross-rs-10-lakh-crore-mcap

* SBI's market cap surpasses Rs10 lakh crore, now India's 6th most valuable firm.
* SBI overtakes ICICI Bank as second-most valuable bank after strong Q3 earnings
* SBI shares hit record high, driven by robust profit and improved asset quality

With its market capitalisation crossing Rs 10 lakh crore, State Bank of India has entered the ranks of India’s most valuable listed companies. The milestone places the state-owned lender alongside Reliance Industries, HDFC Bank, Bharti Airtel, Tata Consultancy Services, and ICICI Bank, making it the sixth Indian firm to achieve the feat.

The state-owned lender also regained its position as the second-most valuable bank by mcap, overtaking ICICI Bank after a gap of more than six years. Earlier, on August 6, 2019, SBI’s market capitalisation stood at Rs 2.69 trillion, slightly above ICICI Bank’s Rs 2.65 trillion.

SBI’s mcap stood at about Rs 10.4 lakh crore, ahead of ICICI Bank’s Rs10.03 lakh crore, according to exchange data. HDFC Bank remains the most valuable bank, with a mcap of Rs 14.47 lakh crore.

SBI shares hit a record high of Rs 1,137 on the BSE, rising 6 percent in a single session following strong December quarter earnings. The stock has gained about 15 percent so far in 2026, after rising more than 25 percent in 2025.

The lender reported a strong performance in the third quarter of FY26, with profit after tax rising 24 percent year-on-year and 4 percent quarter-on-quarter, coming in about 25 percent above analyst estimates. Earnings were supported by one-off items, including dividend income of Rs22 billion, an income-tax refund of Rs7.7 billion, and lower employee benefit provisions of Rs14.3 billion quarter-on-quarter. Even after adjusting for these one-offs, profit remained about 5 percent above estimates.

Net interest income rose 9 percent year-on-year and 5 percent quarter-on-quarter, broadly in line with expectations, aided by strong loan growth of 16 percent year-on-year and 6 percent quarter-on-quarter, along with a 5 basis point sequential expansion in net interest margins. Pre-provision operating profit surged 40 percent year-on-year and 20 percent quarter-on-quarter, supported by strong treasury and foreign exchange income and controlled employee costs.

Asset quality continued to improve, with both gross and net slippages declining by 3 basis points sequentially, while credit costs fell by 10 basis points quarter-on-quarter to 0.40 percent. Management raised its FY26 credit growth guidance to 13 to 15 percent and maintained its exit net interest margin guidance of around 3 percent.

JM Financial said stable margins, efficient cost management, and benign credit costs are expected to support consistent profitability, with average return on assets and return on equity of about 1.0 percent and 15 percent, respectively, over FY27–FY28. The brokerage maintained a buy rating on the stock with a revised target price of Rs 1,250, valuing the core bank at 1.4 times FY28 estimated standalone book value per share.

JM Financial added that strong and diversified growth, resilient margins despite deposit pressures, industry-leading asset quality and sizeable provision buffers underpin SBI’s improved earnings visibility and balance-sheet strength.

Motilal Oswal said SBI delivered a strong all-round performance, led by robust business growth, margin expansion and healthy asset quality. The brokerage noted that net interest margin expanded 2 basis points quarter-on-quarter to 2.99 percent, with domestic margins at 3.12 percent. It said SBI expects net interest margins to remain at 3 percent or higher in FY26 and over the long term.

Motilal Oswal added that credit growth remained healthy at 15.6 percent year-on-year, supported by a strong pipeline, while asset quality continued to improve with benign credit costs of 29 basis points. The brokerage raised its earnings estimates by 3 percent and 4.3 percent for FY27 and FY28, respectively, and reiterated a buy rating with a revised target price of Rs 1,300.

Currently, SBI has 42 buy ratings and seven hold ratings, with no sell recommendations. ICICI Bank has 48 buy ratings and two hold ratings, with no sell ratings, according to analyst data.

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

SBI becomes sixth Indian firm to cross Rs 10 lakh crore mcap

With its market capitalisation crossing Rs 10 lakh crore, State Bank of India has entered the ranks of India’s most valuable listed companies. The milestone places the state-owned lender alongside Reliance Industries, HDFC Bank, Bharti Airtel, Tata Consultancy Services, and ICICI Bank, making it the sixth Indian firm to achieve the feat.

The state-owned lender also regained its position as the second-most valuable bank by mcap, overtaking ICICI Bank after a gap of more than six years. Earlier, on August 6, 2019, SBI’s market capitalisation stood at Rs 2.69 trillion, slightly above ICICI Bank’s Rs 2.65 trillion.

SBI’s mcap stood at about Rs 10.4 lakh crore, ahead of ICICI Bank’s Rs10.03 lakh crore, according to exchange data. HDFC Bank remains the most valuable bank, with a mcap of Rs 14.47 lakh crore.

SBI shares hit a record high of Rs 1,137 on the BSE, rising 6 percent in a single session following strong December quarter earnings. The stock has gained about 15 percent so far in 2026, after rising more than 25 percent in 2025.

The lender reported a strong performance in the third quarter of FY26, with profit after tax rising 24 percent year-on-year and 4 percent quarter-on-quarter, coming in about 25 percent above analyst estimates. Earnings were supported by one-off items, including dividend income of Rs22 billion, an income-tax refund of Rs7.7 billion, and lower employee benefit provisions of Rs14.3 billion quarter-on-quarter. Even after adjusting for these one-offs, profit remained about 5 percent above estimates.

Net interest income rose 9 percent year-on-year and 5 percent quarter-on-quarter, broadly in line with expectations, aided by strong loan growth of 16 percent year-on-year and 6 percent quarter-on-quarter, along with a 5 basis point sequential expansion in net interest margins. Pre-provision operating profit surged 40 percent year-on-year and 20 percent quarter-on-quarter, supported by strong treasury and foreign exchange income and controlled employee costs.

Asset quality continued to improve, with both gross and net slippages declining by 3 basis points sequentially, while credit costs fell by 10 basis points quarter-on-quarter to 0.40 percent. Management raised its FY26 credit growth guidance to 13 to 15 percent and maintained its exit net interest margin guidance of around 3 percent.

JM Financial said stable margins, efficient cost management, and benign credit costs are expected to support consistent profitability, with average return on assets and return on equity of about 1.0 percent and 15 percent, respectively, over FY27–FY28. The brokerage maintained a buy rating on the stock with a revised target price of Rs 1,250, valuing the core bank at 1.4 times FY28 estimated standalone book value per share.

JM Financial added that strong and diversified growth, resilient margins despite deposit pressures, industry-leading asset quality and sizeable provision buffers underpin SBI’s improved earnings visibility and balance-sheet strength.

Motilal Oswal said SBI delivered a strong all-round performance, led by robust business growth, margin expansion and healthy asset quality. The brokerage noted that net interest margin expanded 2 basis points quarter-on-quarter to 2.99 percent, with domestic margins at 3.12 percent. It said SBI expects net interest margins to remain at 3 percent or higher in FY26 and over the long term.

Motilal Oswal added that credit growth remained healthy at 15.6 percent year-on-year, supported by a strong pipeline, while asset quality continued to improve with benign credit costs of 29 basis points. The brokerage raised its earnings estimates by 3 percent and 4.3 percent for FY27 and FY28, respectively, and reiterated a buy rating with a revised target price of Rs 1,300.

Currently, SBI has 42 buy ratings and seven hold ratings, with no sell recommendations. ICICI Bank has 48 buy ratings and two hold ratings, with no sell ratings, according to analyst data.

SBI shares surged nearly 7 percent after strong Q3 results beat expectations, Net profit rose 24.49 percent YoY to Rs 21,028 crore; asset quality improved, Brokerages raised target prices due to strong loan growth and margin performance.

* SBI shares surged nearly 7 percent after strong Q3 results beat expectations
* Net profit rose 24.49 percent YoY to Rs 21,028 crore; asset quality improved
* Brokerages raised target prices due to strong loan growth and margin performance.

SBI shares surged nearly 7% to a record high after strong Q3 results, with net profit up 24.5% YoY and improved asset quality. Brokerages raised target prices, citing robust loan growth, better margins, and lower credit costs.

shorts/business/sbi-shares-jump-7-to-record-high-after-lender-posts-highest-ever-quarterly-profit-in-q3-brokerages-raise-target-prices

* SBI shares surged nearly 7 percent after strong Q3 results beat expectations
* Net profit rose 24.49 percent YoY to Rs 21,028 crore; asset quality improved
* Brokerages raised target prices due to strong loan growth and margin performance.

The shares of State Bank of India (<a href="https://www.moneycontrol.com/india/stockpricequote/banks-public-sector/statebankindia/SBI">SBI</a>) jumped nearly 7 percent to a fresh record high on February 9 after the public lender’s Q3 results surpassed expectations. Several brokerages raised their target prices for the stock.

The shares of the company hit a fresh 52-week high of Rs 1,137 apiece in the morning trading hours of Monday.
<h3>SBI Q3 Results:</h3>
SBI on February 7 reported a net profit after minority interest of Rs 21,028.15 crore for the October-December quarter of the ongoing financial year 2026. This is the highest-ever quaterly net profit reported by the banking behemoth.

This marks a <a href="https://www.moneycontrol.com/news/business/earnings/sbi-q3fy26-profit-jumps-24-5-to-rs-21-028-crore-gross-npa-ratio-improves-to-1-57-13816638.html">24.49 percent year-on-year (YoY) increase</a> from the Rs 16,891.44 crore net profit reported in the same quarter of the previous financial year.

The public lender’s net interest income (NII) meanwhile grew 9 percent YoY to Rs 45,190 crore during the quarter under review from Rs 41,445 crore in the year-ago period, reflecting steady growth in core lending income.

Sequentially, SBI’s asset quality improved, with gross NPA ratio improving to 1.57 percent in Q3 FY26 from 1.73 percent in Q2 FY26. Net NPA ratio meanwhile declined to 0.39 percent in Q3 FY26 from 0.42 percent in Q2 FY26.

Provisions for the quarter stood at Rs 4,506 crore, lower than Rs 5,400 crore in the previous quarter and sharply down from Rs 911 crore a year earlier, indicating easing credit costs.
<h3>Nomura on SBI:</h3>
Nomura maintained its ‘Buy’ call on SBI shares, while raising its target price to Rs 1,235 apiece. This implies an upside potential of nearly 16 percent from the stock’s previous closing price.

The international brokerage said that the company delivered an “strong all-round” performance during the quarter, with better margin delivery and loan growth in comparison to its peers. It added that strong NIM performance, controlled opex and higher other income drove a beat on profit after tax.

Nomura further noted that loan growth was strong and broad based, while asset quality remained stable. Incremental upside is expected to be largely earnings-driven, rather than multiple-led, it added.
<h3>CLSA on SBI:</h3>
CLSA maintained an ‘Outperform’ rating on the stock, while raising its target price to Rs 1,275 apiece. This implies an upside potential of nearly 20 percent from the stock’s previous closing price.

The international brokerage said that the lender posted Stronger-than-expected Q3 results, with core PPoP and PBT beating estimates by 4-11 percent.

Loan growth picked up from 13 percent to 15 percent YoY, and sequential loan growth outperformed PSU peers as well as large private banks, it added. Margin improved 2 bps QoQ to 3 percent due to a lower cost of deposits, it said, adding that slippages declined sequentially and credit costs were much better than expected.

Follow all <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-gap-up-start-us-asian-markets-gain-liveblog-13817633.html">LIVE updates</a> on stock markets here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

SBI shares jump 7% to record high after lender posts highest-ever quarterly profit in Q3: Brokerages raise target prices

The shares of State Bank of India (SBI) jumped nearly 7 percent to a fresh record high on February 9 after the public lender’s Q3 results surpassed expectations. Several brokerages raised their target prices for the stock.

The shares of the company hit a fresh 52-week high of Rs 1,137 apiece in the morning trading hours of Monday.
SBI Q3 Results:
SBI on February 7 reported a net profit after minority interest of Rs 21,028.15 crore for the October-December quarter of the ongoing financial year 2026. This is the highest-ever quaterly net profit reported by the banking behemoth.

This marks a 24.49 percent year-on-year (YoY) increase from the Rs 16,891.44 crore net profit reported in the same quarter of the previous financial year.

The public lender’s net interest income (NII) meanwhile grew 9 percent YoY to Rs 45,190 crore during the quarter under review from Rs 41,445 crore in the year-ago period, reflecting steady growth in core lending income.

Sequentially, SBI’s asset quality improved, with gross NPA ratio improving to 1.57 percent in Q3 FY26 from 1.73 percent in Q2 FY26. Net NPA ratio meanwhile declined to 0.39 percent in Q3 FY26 from 0.42 percent in Q2 FY26.

Provisions for the quarter stood at Rs 4,506 crore, lower than Rs 5,400 crore in the previous quarter and sharply down from Rs 911 crore a year earlier, indicating easing credit costs.
Nomura on SBI:
Nomura maintained its ‘Buy’ call on SBI shares, while raising its target price to Rs 1,235 apiece. This implies an upside potential of nearly 16 percent from the stock’s previous closing price.

The international brokerage said that the company delivered an “strong all-round” performance during the quarter, with better margin delivery and loan growth in comparison to its peers. It added that strong NIM performance, controlled opex and higher other income drove a beat on profit after tax.

Nomura further noted that loan growth was strong and broad based, while asset quality remained stable. Incremental upside is expected to be largely earnings-driven, rather than multiple-led, it added.
CLSA on SBI:
CLSA maintained an ‘Outperform’ rating on the stock, while raising its target price to Rs 1,275 apiece. This implies an upside potential of nearly 20 percent from the stock’s previous closing price.

The international brokerage said that the lender posted Stronger-than-expected Q3 results, with core PPoP and PBT beating estimates by 4-11 percent.

Loan growth picked up from 13 percent to 15 percent YoY, and sequential loan growth outperformed PSU peers as well as large private banks, it added. Margin improved 2 bps QoQ to 3 percent due to a lower cost of deposits, it said, adding that slippages declined sequentially and credit costs were much better than expected.

Follow all LIVE updates on stock markets here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/aurobindopharma/AP">Aurobindo Pharma</a> share price gained marginally on February 9 despite the company received 11 observations following an inspection from United States Food and Drug Administration (USFDA).

At 09:30am, Aurobindo Pharma was quoting at Rs 1,195, up Rs 3.85, or 0.32 percent, on the BSE.

The USFDA inspected unit-III, a formulation manufacturing facility, of Eugia Pharma Specialities, a wholly owned subsidiary of the company, situated at Telangana.

The said inspection done between January 27 to February 06, 2026.

The inspection concluded with 11 observations, which are procedural in nature and will be responded to within the stipulated time, company said.

<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-gap-up-start-us-asian-markets-gain-liveblog-13817633.html">Catch all the market action on our live blog</a>

In the previous trading session, the stock closed at ₹1,191.15, gaining ₹8.65, or 0.73 percent. The share has touched a 52-week high of ₹1,278 on April 24, 2025, and a 52-week low of ₹994.35 on April 7, 2025.

At current levels, the stock is trading about 6.8 percent below its 52-week high and nearly 19.79 percent above its 52-week low. The company’s market capitalisation stands at ₹69,182.19 crore.

Aurobindo Pharma receives 11 observations from USFDA; stock price flat

Aurobindo Pharma share price gained marginally on February 9 despite the company received 11 observations following an inspection from United States Food and Drug Administration (USFDA).

At 09:30am, Aurobindo Pharma was quoting at Rs 1,195, up Rs 3.85, or 0.32 percent, on the BSE.

The USFDA inspected unit-III, a formulation manufacturing facility, of Eugia Pharma Specialities, a wholly owned subsidiary of the company, situated at Telangana.

The said inspection done between January 27 to February 06, 2026.

The inspection concluded with 11 observations, which are procedural in nature and will be responded to within the stipulated time, company said.

Catch all the market action on our live blog

In the previous trading session, the stock closed at ₹1,191.15, gaining ₹8.65, or 0.73 percent. The share has touched a 52-week high of ₹1,278 on April 24, 2025, and a 52-week low of ₹994.35 on April 7, 2025.

At current levels, the stock is trading about 6.8 percent below its 52-week high and nearly 19.79 percent above its 52-week low. The company’s market capitalisation stands at ₹69,182.19 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-lcvshcvs/forcemotors/FM01">Force Motors</a>’ share price touched 52-week high of Rs 22,200 after the company entered into a Memorandum of Understanding (MoU) to acquire full control of Veera Tanneries.

At 09:29 hrs Force Motors was quoting at Rs 21,849.95, up Rs 431.10, or 2.01 percent, on the BSE.

Force Motors, Veera Tanneries (VTPL), and the shareholders of VTPL executed the MoU on Friday, February 6, 2026, for the acquisition of 100% equity stake in VTPL. The total consideration for the transaction stands at Rs 175 crore.

<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-gap-up-start-us-asian-markets-gain-liveblog-13817633.html">Catch all the market action on our live blog</a>

For the quarter ended December (Q3FY26), the company reported a 252% surge in consolidated net profit to Rs 406.1 crore, compared with Rs 115.3 crore in the corresponding period last year.

Revenue rose 12.7% year-on-year to Rs 2,128.6 crore, up from Rs 1,889.5 crore.

The performance was supported by exceptional gains of Rs 211.2 crore, as against nil in the year-ago quarter.

The company’s total sales for January rose 4.6% year-on-year to 3,764 units, compared with 3,597 units in the same month last year.

Domestic sales increased 4.92% to 3,665 units, while exports declined 4.81% to 99 units, down from 104 units a year ago.

The share price surged 230 percent in the last one-year.

Force Motors shares hit 52-week high on plan to acquire 100% stake in Veera Tanneries

Force Motors’ share price touched 52-week high of Rs 22,200 after the company entered into a Memorandum of Understanding (MoU) to acquire full control of Veera Tanneries.

At 09:29 hrs Force Motors was quoting at Rs 21,849.95, up Rs 431.10, or 2.01 percent, on the BSE.

Force Motors, Veera Tanneries (VTPL), and the shareholders of VTPL executed the MoU on Friday, February 6, 2026, for the acquisition of 100% equity stake in VTPL. The total consideration for the transaction stands at Rs 175 crore.

Catch all the market action on our live blog

For the quarter ended December (Q3FY26), the company reported a 252% surge in consolidated net profit to Rs 406.1 crore, compared with Rs 115.3 crore in the corresponding period last year.

Revenue rose 12.7% year-on-year to Rs 2,128.6 crore, up from Rs 1,889.5 crore.

The performance was supported by exceptional gains of Rs 211.2 crore, as against nil in the year-ago quarter.

The company’s total sales for January rose 4.6% year-on-year to 3,764 units, compared with 3,597 units in the same month last year.

Domestic sales increased 4.92% to 3,665 units, while exports declined 4.81% to 99 units, down from 104 units a year ago.

The share price surged 230 percent in the last one-year.

Stocks in focus on Feb 9: Kalyan Jewellers, GMM Pfaudler, Sula Vineyards, Sun TV Network, Ipca Laboratories, Power Finance Corporation, REC, Biocon, Tata Chemicals, Aurobindo Pharma, BEML, Force Motors

* Stocks in focus on Feb 9: Kalyan Jewellers, GMM Pfaudler, Sula Vineyards, Sun TV Network, Ipca Laboratories, Power Finance Corporation, REC, Biocon, Tata Chemicals, Aurobindo Pharma, BEML, Force Motors

shorts/business/stocks-to-watch-today-sbi-aurobindo-pharma-ipca-labs-tata-steel-pfc-rec-force-motors-kalyan-jewellers-jk-tyre-ram-ratna-wires-atul-auto-in-focus-on-09-february

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Results Today</a>

Zydus Lifesciences, Aurobindo Pharma, All Time Plastics, Amber Enterprises India, Bajaj Electricals, Bata India, Enviro Infra Engineers, PNGS Gargi Fashion Jewellery, GlaxoSmithKline Pharmaceuticals, Happiest Minds Technologies, Navin Fluorine International, P N Gadgil Jewellers, Ramco Cements, Sun Pharma Advanced Research Company, Trident, and Vadilal Industries will release quarterly earnings today.

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Quarterly Earnings</a>

<a href="https://www.moneycontrol.com/india/stockpricequote/banks-public-sector/statebankindia/SBI" target="_blank">State Bank of India</a> Q3 (Standalone YoY)

Profit soars 24.5% to Rs 21,028.2 crore Vs Rs 16,891.4 crore

Net interest income grows 9% to Rs 45,190.4 crore Vs Rs 41,445.5 crore

Other income zooms 66.3% to Rs 18,358.5 crore Vs Rs 11,040.8 crore

Operating profit jumps 39.5% to Rs 32,862.4 crore Vs Rs 23,550.8 crore

Provisions and contingences spike 5-fold to Rs 4,506.9 crore Vs Rs 911.1 crore

Gross NPA falls to 1.57% Vs 1.73% (QoQ)

Net NPA declines to 0.39% Vs 0.42% (QoQ)

<a href="https://www.moneycontrol.com/india/stockpricequote/ironsteel/tatasteel/TIS" target="_blank">Tata Steel</a> Q3 (Consolidated YoY)

Profit jumps over 9-fold to Rs 2,730.4 crore Vs Rs 295.5 crore

Revenue rises 6.3% to Rs 57,002.4 crore Vs Rs 53,648.3 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/cement-major/shreecements/SC12" target="_blank">Shree Cement</a> Q3 (Consolidated YoY)

Profit zooms 37.9% to Rs 266.7 crore Vs Rs 193.4 crore

Revenue grows 5% to Rs 4,800.5 crore Vs Rs 4,572.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-ancillaries/bosch/B05" target="_blank">Bosch</a> Q3 (Consolidated YoY)

Profit rises 16.2% to Rs 532.1 crore Vs Rs 458.1 crore

Revenue increases 9.4% to Rs 4,885.6 crore Vs Rs 4,465.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/engineering-industrial-equipments/oswalpumps/OPL02" target="_blank">Oswal Pumps</a> Q3 (Consolidated YoY)

Profit grows 13.9% to Rs 91.6 crore Vs Rs 80.4 crore

Revenue soars 32% to Rs 501.1 crore Vs Rs 379.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/electric-equipment/hblengineering/HBL02" target="_blank">HBL Engineering</a> Q3 (Consolidated YoY)

Profit zooms over 3-fold to Rs 220.6 crore Vs Rs 64.6 crore

Revenue jumps 94% to Rs 874 crore Vs Rs 450.6 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/smspharmaceuticals/SP38" target="_blank">SMS Pharmaceuticals</a> Q3 (Consolidated YoY)

Profit soars 28.7% to Rs 23.5 crore Vs Rs 18.2 crore

Revenue increases 21.4% to Rs 210.4 crore Vs Rs 173.4 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/steel-sponge-iron/sardaenergyminerals/SEM" target="_blank">Sarda Energy and Minerals</a> Q3 (Consolidated YoY)

Profit slips 3.5% to Rs 190.4 crore Vs Rs 197.4 crore

Revenue declines 3.3% to Rs 1,276 crore Vs Rs 1,319.1 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-23-wheelers/atulauto/AA08" target="_blank">Atul Auto</a> Q3 (Consolidated YoY)

Profit spikes 98% to Rs 15.4 crore Vs Rs 7.8 crore

Revenue jumps 18.4% to Rs 230.9 crore Vs Rs 195 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/hospitalhealthcare-services/krishnainstitutemedicalsciences/KIo01" target="_blank">Krishna Institute of Medical Sciences</a> Q3 (Consolidated YoY)

Profit declines 39.8% to Rs 53.4 crore Vs Rs 88.7 crore

Revenue grows 29.2% to Rs 997.7 crore Vs Rs 772.4 crore

Other income falls to Rs 5.2 crore Vs Rs 17.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/metals-non-ferrous/ramratnawires/RRW" target="_blank">Ram Ratna Wires</a> Q3 (Consolidated YoY)

Profit zooms 73.1% to Rs 31.3 crore Vs Rs 18.1 crore

Revenue surges 43.8% to Rs 1,277.9 crore Vs Rs 888.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/tyres/jktyreindustries/JKT01" target="_blank">JK Tyre and Industries</a> Q3 (Consolidated YoY)

Profit grows four-fold to Rs 207.8 crore Vs Rs 52.6 crore

Revenue jumps 15% to Rs 4,223 crore Vs Rs 3,673.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/consumer-goods-white-goods/whirlpoolindia/WI" target="_blank">Whirlpool of India</a> Q3 (Consolidated YoY)

Profit sinks 39.7% to Rs 26.5 crore Vs Rs 44 crore

Revenue rises 4% to Rs 1,773.8 crore Vs Rs 1,704.9 crore

Exceptional loss stands at Rs 38.84 crore Vs Nil

<a href="https://www.moneycontrol.com/india/stockpricequote/steel-sponge-iron/godawaripowerispat/GPI7" target="_blank">Godawari Power and Ispat</a> Q3 (Consolidated YoY)

Profit drops 1.1% to Rs 143.3 crore Vs Rs 144.8 crore

Revenue declines 12.2% to Rs 1,139.5 crore Vs Rs 1,297.6 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/computers-software-mediumsmall/sonatasoftware/SS42" target="_blank">Sonata Software</a> Q3 (Consolidated YoY)

Profit falls 0.6% to Rs 104.4 crore Vs Rs 105 crore

Revenue grows 8.4% to Rs 3,080.6 crore Vs Rs 2,842.8 crore

Labour code impact stands at Rs 31.28 crore Vs Nil

Other income drops to Rs 11.4 crore Vs Rs 21.49 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/diamondjewellery/kalyanjewellersindia/KJI01" target="_blank">Kalyan Jewellers</a> Q3 (Consolidated YoY)

Profit zooms 90.2% to Rs 416.3 crore Vs Rs 218.8 crore

Revenue surges 42.1% to Rs 10,343.4 crore Vs Rs 7,278.1 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/engineering-heavy/gmmpfaudler/GMM01" target="_blank">GMM Pfaudler</a> Q3 (Consolidated YoY)

Loss stands at Rs 8 crore Vs profit of Rs 41.5 crore

Revenue jumps 10.2% to Rs 883.5 crore Vs Rs 801.5 crore

Exceptional loss stands at Rs 56.32 crore Vs Nil

<a href="https://www.moneycontrol.com/india/stockpricequote/electricals/cromptongreavesconsumerelectrical/CGC01" target="_blank">Crompton Greaves Consumer Electricals</a> Q3 (Consolidated YoY)

Profit declines 9.8% to Rs 101 crore Vs Rs 111.9 crore

Revenue increases 7.3% to Rs 1,898.3 crore Vs Rs 1,769.4 crore

Exceptional loss stands at Rs 20 crore Vs Nil

<a href="https://www.moneycontrol.com/india/stockpricequote/breweriesdistilleries/sulavineyards/SV01" target="_blank">Sula Vineyards</a> Q3 (Consolidated YoY)

Profit drops 67.6% to Rs 9.1 crore Vs Rs 28 crore

Revenue slips 9.7% to Rs 195.7 crore Vs Rs 216.6 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/mediaentertainment/suntvnetwork/STN01" target="_blank">Sun TV Network</a> Q3 (Consolidated YoY)

Profit declines 10.8% to Rs 324 crore Vs Rs 363.4 crore

Revenue rises 4% to Rs 862.2 crore Vs Rs 828.8 crore

Stocks to Watch

<a href="https://www.moneycontrol.com/india/stockpricequote/refineries/relianceindustries/RI" target="_blank">Reliance Industries</a>

Reliance Consumer Products, the FMCG subsidiary of Reliance Industries, has acquired a majority stake in Australia’s popular “better-for-you” beverage company, Goodness Group Global (GGG).

Under the strategic partnership, Reliance Consumer Products will help promote Goodness Group’s flagship healthy beverage brands, such as Nexba and PACE—a hydration brand co-created with Australian cricket captain Pat Cummins—across new markets, including India.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/ipcalaboratories/IL" target="_blank">Ipca Laboratories</a>

The company’s Active Pharmaceutical Ingredients (API) manufacturing facility at Tarapur (Palghar, Maharashtra) has received the Establishment Inspection Report, classifying the facility as Voluntary Action Indicated (VAI). This indicates that the facility is in a minimally acceptable state of compliance with current good manufacturing practices (CGMP).

The US FDA inspected the said manufacturing facility from December 1 and December 5, 2025.

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-term-lending-institutions/powerfinancecorporation/PFC02" target="_blank">Power Finance Corporation</a>, <a href="https://www.moneycontrol.com/india/stockpricequote/finance-term-lending-institutions/rec/REC02" target="_blank">REC</a>

Following the in-principle approval of the Cabinet Committee on Economic Affairs (CCEA), Power Finance Corporation (PFC) has acquired 52.63 percent of the government’s shareholding in REC. Accordingly, PFC and REC are now operating as holding and subsidiary companies.

The Board of Directors of PFC took note of the Budget announcement and accorded its in-principle approval for restructuring in the form of a merger between PFC and REC, while ensuring that the merged entity continues to remain a government company.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/biocon/BL03" target="_blank">Biocon</a>

Fitch Ratings has revised the outlook on the company’s Long-Term Foreign-Currency Issuer Default Rating (IDR) from Stable to Positive, while affirming the rating at ‘BB-’. Fitch has also affirmed the ‘BB’ rating on the company’s $800 million secured notes issued by its subsidiary, Biocon Biologics Global Plc.

Fitch said the positive outlook reflects its expectation of a sustained reduction in Biocon’s financial leverage following the reduction of liabilities using proceeds from a recent equity issuance.

<a href="https://www.moneycontrol.com/india/stockpricequote/chemicals/tatachemicals/TC" target="_blank">Tata Chemicals</a>

The company has announced an investment of Rs 515 crore to set up a new greenfield manufacturing facility in Tamil Nadu as part of its capacity expansion and supply-chain strengthening strategy. The facility will manufacture iodised vacuum salt dried (IVSD) and will have an installed capacity of 210 kilo tonnes per annum (KTPA).

Tata Chemicals expects to complete the project within 36 months and will fund the investment through internal accruals and/or external financing.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/aurobindopharma/AP" target="_blank">Aurobindo Pharma</a>

The United States Food and Drug Administration (US FDA) inspected Unit III, a formulation manufacturing facility of Eugia Pharma Specialities—a wholly owned subsidiary of the company—at Pashamylaram, Telangana, from January 27 to February 6.

The inspection concluded with 11 observations, which the company said are procedural in nature.

<a href="https://www.moneycontrol.com/india/stockpricequote/infrastructure-general/beml/BEM03" target="_blank">BEML</a>

The Board has approved an estimated investment of approximately Rs 1,500 crore for a greenfield rail manufacturing facility, ‘BRAHMA’, at Umariya in Madhya Pradesh. The project is expected to be completed in a phased manner over five years.

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-lcvshcvs/forcemotors/FM01" target="_blank">Force Motors</a>

The company has executed a Memorandum of Understanding to acquire 100 percent equity shares in Veera Tanneries for Rs 175 crore, subject to the deduction of applicable taxes.

<a href="https://www.moneycontrol.com/india/stockpricequote/power-generationdistribution/indianrenewableenergydevelopmentagency/IREDAL" target="_blank">Indian Renewable Energy Development Agency</a>

The Board has approved raising funds of up to Rs 2,994 crore through a Qualified Institutions Placement (QIP) in one or more tranches, provided that the government’s shareholding—acting through the Ministry of New and Renewable Energy—does not dilute by more than 3.76 percent of the post-issue paid-up equity share capital of the company.

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-carsjeeps/mahindramahindra/MM" target="_blank">Mahindra and Mahindra</a>

Mahindra Industrial Park Chennai (MIPCL), a joint venture between Mahindra World City Developers and Japan’s Sumitomo Corporation, has announced the commencement of operations of Mitsubishi Electric India’s air-conditioner and compressor manufacturing facility at Origins by Mahindra in Chennai.

Developed with an investment of Rs 2,100 crore, the facility underscores Mitsubishi Electric India’s long-term commitment to the Indian market.

With an annual production capacity of 3 lakh indoor and outdoor room air conditioners and 6.5 lakh compressors, the expansion supports the development of a strong regional supplier ecosystem and aligns with the Government of India’s “Make in India” initiative.

Bulk Deals

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-investment/sgfinserve/MS29" target="_blank">SG Finserve</a>

Promoter S Gupta Holding has purchased 3 lakh shares, representing 0.53 percent of the paid-up equity capital of SG Finserve, at Rs 356.32 per share, amounting to Rs 10.68 crore.

Bartronics India

Investor Scan Help Technologies has sold 21.55 lakh shares, representing a 0.7 percent stake in Bartronics India, at Rs 15.13 per share, valued at Rs 3.26 crore. Scan Help held a 4.56 percent stake in the company as of December 2025.

Stocks Trade Ex-Dividend

Aarti Drugs
Bharat Dynamics
Container Corporation of India
Power Grid Corporation of India
Prithvi Exchange (India)
Triveni Turbine

Stock Trades Ex-Date for Buy Back

Go Fashion (India)

Stock Trades Ex-Date for Resolution Plan -Suspension

Indus Fila

Stock in F&amp;O ban

Sammaan Capital

Disclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

Stocks to Watch Today: SBI, Aurobindo Pharma, Ipca Labs, Tata Steel, PFC, REC, Force Motors, Kalyan Jewellers, JK Tyre, Ram Ratna Wires, Atul Auto in focus on 09 February

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:

Results Today

Zydus Lifesciences, Aurobindo Pharma, All Time Plastics, Amber Enterprises India, Bajaj Electricals, Bata India, Enviro Infra Engineers, PNGS Gargi Fashion Jewellery, GlaxoSmithKline Pharmaceuticals, Happiest Minds Technologies, Navin Fluorine International, P N Gadgil Jewellers, Ramco Cements, Sun Pharma Advanced Research Company, Trident, and Vadilal Industries will release quarterly earnings today.

Quarterly Earnings

State Bank of India Q3 (Standalone YoY)

Profit soars 24.5% to Rs 21,028.2 crore Vs Rs 16,891.4 crore

Net interest income grows 9% to Rs 45,190.4 crore Vs Rs 41,445.5 crore

Other income zooms 66.3% to Rs 18,358.5 crore Vs Rs 11,040.8 crore

Operating profit jumps 39.5% to Rs 32,862.4 crore Vs Rs 23,550.8 crore

Provisions and contingences spike 5-fold to Rs 4,506.9 crore Vs Rs 911.1 crore

Gross NPA falls to 1.57% Vs 1.73% (QoQ)

Net NPA declines to 0.39% Vs 0.42% (QoQ)

Tata Steel Q3 (Consolidated YoY)

Profit jumps over 9-fold to Rs 2,730.4 crore Vs Rs 295.5 crore

Revenue rises 6.3% to Rs 57,002.4 crore Vs Rs 53,648.3 crore

Shree Cement Q3 (Consolidated YoY)

Profit zooms 37.9% to Rs 266.7 crore Vs Rs 193.4 crore

Revenue grows 5% to Rs 4,800.5 crore Vs Rs 4,572.7 crore

Bosch Q3 (Consolidated YoY)

Profit rises 16.2% to Rs 532.1 crore Vs Rs 458.1 crore

Revenue increases 9.4% to Rs 4,885.6 crore Vs Rs 4,465.7 crore

Oswal Pumps Q3 (Consolidated YoY)

Profit grows 13.9% to Rs 91.6 crore Vs Rs 80.4 crore

Revenue soars 32% to Rs 501.1 crore Vs Rs 379.7 crore

HBL Engineering Q3 (Consolidated YoY)

Profit zooms over 3-fold to Rs 220.6 crore Vs Rs 64.6 crore

Revenue jumps 94% to Rs 874 crore Vs Rs 450.6 crore

SMS Pharmaceuticals Q3 (Consolidated YoY)

Profit soars 28.7% to Rs 23.5 crore Vs Rs 18.2 crore

Revenue increases 21.4% to Rs 210.4 crore Vs Rs 173.4 crore

Sarda Energy and Minerals Q3 (Consolidated YoY)

Profit slips 3.5% to Rs 190.4 crore Vs Rs 197.4 crore

Revenue declines 3.3% to Rs 1,276 crore Vs Rs 1,319.1 crore

Atul Auto Q3 (Consolidated YoY)

Profit spikes 98% to Rs 15.4 crore Vs Rs 7.8 crore

Revenue jumps 18.4% to Rs 230.9 crore Vs Rs 195 crore

Krishna Institute of Medical Sciences Q3 (Consolidated YoY)

Profit declines 39.8% to Rs 53.4 crore Vs Rs 88.7 crore

Revenue grows 29.2% to Rs 997.7 crore Vs Rs 772.4 crore

Other income falls to Rs 5.2 crore Vs Rs 17.8 crore

Ram Ratna Wires Q3 (Consolidated YoY)

Profit zooms 73.1% to Rs 31.3 crore Vs Rs 18.1 crore

Revenue surges 43.8% to Rs 1,277.9 crore Vs Rs 888.7 crore

JK Tyre and Industries Q3 (Consolidated YoY)

Profit grows four-fold to Rs 207.8 crore Vs Rs 52.6 crore

Revenue jumps 15% to Rs 4,223 crore Vs Rs 3,673.7 crore

Whirlpool of India Q3 (Consolidated YoY)

Profit sinks 39.7% to Rs 26.5 crore Vs Rs 44 crore

Revenue rises 4% to Rs 1,773.8 crore Vs Rs 1,704.9 crore

Exceptional loss stands at Rs 38.84 crore Vs Nil

Godawari Power and Ispat Q3 (Consolidated YoY)

Profit drops 1.1% to Rs 143.3 crore Vs Rs 144.8 crore

Revenue declines 12.2% to Rs 1,139.5 crore Vs Rs 1,297.6 crore

Sonata Software Q3 (Consolidated YoY)

Profit falls 0.6% to Rs 104.4 crore Vs Rs 105 crore

Revenue grows 8.4% to Rs 3,080.6 crore Vs Rs 2,842.8 crore

Labour code impact stands at Rs 31.28 crore Vs Nil

Other income drops to Rs 11.4 crore Vs Rs 21.49 crore

Kalyan Jewellers Q3 (Consolidated YoY)

Profit zooms 90.2% to Rs 416.3 crore Vs Rs 218.8 crore

Revenue surges 42.1% to Rs 10,343.4 crore Vs Rs 7,278.1 crore

GMM Pfaudler Q3 (Consolidated YoY)

Loss stands at Rs 8 crore Vs profit of Rs 41.5 crore

Revenue jumps 10.2% to Rs 883.5 crore Vs Rs 801.5 crore

Exceptional loss stands at Rs 56.32 crore Vs Nil

Crompton Greaves Consumer Electricals Q3 (Consolidated YoY)

Profit declines 9.8% to Rs 101 crore Vs Rs 111.9 crore

Revenue increases 7.3% to Rs 1,898.3 crore Vs Rs 1,769.4 crore

Exceptional loss stands at Rs 20 crore Vs Nil

Sula Vineyards Q3 (Consolidated YoY)

Profit drops 67.6% to Rs 9.1 crore Vs Rs 28 crore

Revenue slips 9.7% to Rs 195.7 crore Vs Rs 216.6 crore

Sun TV Network Q3 (Consolidated YoY)

Profit declines 10.8% to Rs 324 crore Vs Rs 363.4 crore

Revenue rises 4% to Rs 862.2 crore Vs Rs 828.8 crore

Stocks to Watch

Reliance Industries

Reliance Consumer Products, the FMCG subsidiary of Reliance Industries, has acquired a majority stake in Australia’s popular “better-for-you” beverage company, Goodness Group Global (GGG).

Under the strategic partnership, Reliance Consumer Products will help promote Goodness Group’s flagship healthy beverage brands, such as Nexba and PACE—a hydration brand co-created with Australian cricket captain Pat Cummins—across new markets, including India.

Ipca Laboratories

The company’s Active Pharmaceutical Ingredients (API) manufacturing facility at Tarapur (Palghar, Maharashtra) has received the Establishment Inspection Report, classifying the facility as Voluntary Action Indicated (VAI). This indicates that the facility is in a minimally acceptable state of compliance with current good manufacturing practices (CGMP).

The US FDA inspected the said manufacturing facility from December 1 and December 5, 2025.

Power Finance Corporation, REC

Following the in-principle approval of the Cabinet Committee on Economic Affairs (CCEA), Power Finance Corporation (PFC) has acquired 52.63 percent of the government’s shareholding in REC. Accordingly, PFC and REC are now operating as holding and subsidiary companies.

The Board of Directors of PFC took note of the Budget announcement and accorded its in-principle approval for restructuring in the form of a merger between PFC and REC, while ensuring that the merged entity continues to remain a government company.

Biocon

Fitch Ratings has revised the outlook on the company’s Long-Term Foreign-Currency Issuer Default Rating (IDR) from Stable to Positive, while affirming the rating at ‘BB-’. Fitch has also affirmed the ‘BB’ rating on the company’s $800 million secured notes issued by its subsidiary, Biocon Biologics Global Plc.

Fitch said the positive outlook reflects its expectation of a sustained reduction in Biocon’s financial leverage following the reduction of liabilities using proceeds from a recent equity issuance.

Tata Chemicals

The company has announced an investment of Rs 515 crore to set up a new greenfield manufacturing facility in Tamil Nadu as part of its capacity expansion and supply-chain strengthening strategy. The facility will manufacture iodised vacuum salt dried (IVSD) and will have an installed capacity of 210 kilo tonnes per annum (KTPA).

Tata Chemicals expects to complete the project within 36 months and will fund the investment through internal accruals and/or external financing.

Aurobindo Pharma

The United States Food and Drug Administration (US FDA) inspected Unit III, a formulation manufacturing facility of Eugia Pharma Specialities—a wholly owned subsidiary of the company—at Pashamylaram, Telangana, from January 27 to February 6.

The inspection concluded with 11 observations, which the company said are procedural in nature.

BEML

The Board has approved an estimated investment of approximately Rs 1,500 crore for a greenfield rail manufacturing facility, ‘BRAHMA’, at Umariya in Madhya Pradesh. The project is expected to be completed in a phased manner over five years.

Force Motors

The company has executed a Memorandum of Understanding to acquire 100 percent equity shares in Veera Tanneries for Rs 175 crore, subject to the deduction of applicable taxes.

Indian Renewable Energy Development Agency

The Board has approved raising funds of up to Rs 2,994 crore through a Qualified Institutions Placement (QIP) in one or more tranches, provided that the government’s shareholding—acting through the Ministry of New and Renewable Energy—does not dilute by more than 3.76 percent of the post-issue paid-up equity share capital of the company.

Mahindra and Mahindra

Mahindra Industrial Park Chennai (MIPCL), a joint venture between Mahindra World City Developers and Japan’s Sumitomo Corporation, has announced the commencement of operations of Mitsubishi Electric India’s air-conditioner and compressor manufacturing facility at Origins by Mahindra in Chennai.

Developed with an investment of Rs 2,100 crore, the facility underscores Mitsubishi Electric India’s long-term commitment to the Indian market.

With an annual production capacity of 3 lakh indoor and outdoor room air conditioners and 6.5 lakh compressors, the expansion supports the development of a strong regional supplier ecosystem and aligns with the Government of India’s “Make in India” initiative.

Bulk Deals

SG Finserve

Promoter S Gupta Holding has purchased 3 lakh shares, representing 0.53 percent of the paid-up equity capital of SG Finserve, at Rs 356.32 per share, amounting to Rs 10.68 crore.

Bartronics India

Investor Scan Help Technologies has sold 21.55 lakh shares, representing a 0.7 percent stake in Bartronics India, at Rs 15.13 per share, valued at Rs 3.26 crore. Scan Help held a 4.56 percent stake in the company as of December 2025.

Stocks Trade Ex-Dividend

Aarti Drugs
Bharat Dynamics
Container Corporation of India
Power Grid Corporation of India
Prithvi Exchange (India)
Triveni Turbine

Stock Trades Ex-Date for Buy Back

Go Fashion (India)

Stock Trades Ex-Date for Resolution Plan -Suspension

Indus Fila

Stock in F&amp;amp;O ban

Sammaan Capital

Disclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

Food Processing Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Food Processing industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q3 FY25-26

Stock News

SBI becomes sixth Indian firm to cross Rs 10 lakh crore mcap

SBI shares jump 7% to record high after lender posts highest-ever quarterly profit in Q3: Brokerages raise target prices

Aurobindo Pharma receives 11 observations from USFDA; stock price flat

Force Motors shares hit 52-week high on plan to acquire 100% stake in Veera Tanneries

Stocks to Watch Today: SBI, Aurobindo Pharma, Ipca Labs, Tata Steel, PFC, REC, Force Motors, Kalyan Jewellers, JK Tyre, Ram Ratna Wires, Atul Auto in focus on 09 February

Food Processing Industry StocksCheck latest stock performance, list of stocks, earnings review & more details about the Food Processing industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q3 FY25-26

Stock News

SBI becomes sixth Indian firm to cross Rs 10 lakh crore mcap

SBI shares jump 7% to record high after lender posts highest-ever quarterly profit in Q3: Brokerages raise target prices

Aurobindo Pharma receives 11 observations from USFDA; stock price flat

Force Motors shares hit 52-week high on plan to acquire 100% stake in Veera Tanneries

Stocks to Watch Today: SBI, Aurobindo Pharma, Ipca Labs, Tata Steel, PFC, REC, Force Motors, Kalyan Jewellers, JK Tyre, Ram Ratna Wires, Atul Auto in focus on 09 February

Food Processing Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Food Processing industry stocks.